Literature DB >> 19325146

Therapeutic neovascularization by nanotechnology-mediated cell-selective delivery of pitavastatin into the vascular endothelium.

Mitsuki Kubo1, Kensuke Egashira, Takahiro Inoue, Jun-ichiro Koga, Shinichiro Oda, Ling Chen, Kaku Nakano, Tetsuya Matoba, Yoshiaki Kawashima, Kaori Hara, Hiroyuki Tsujimoto, Katsuo Sueishi, Ryuji Tominaga, Kenji Sunagawa.   

Abstract

OBJECTIVE: Recent clinical studies of therapeutic neovascularization using angiogenic growth factors demonstrated smaller therapeutic effects than those reported in animal experiments. We hypothesized that nanoparticle (NP)-mediated cell-selective delivery of statins to vascular endothelium would more effectively and integratively induce therapeutic neovascularization. METHODS AND
RESULTS: In a murine hindlimb ischemia model, intramuscular injection of biodegradable polymeric NP resulted in cell-selective delivery of NP into the capillary and arteriolar endothelium of ischemic muscles for up to 2 weeks postinjection. NP-mediated statin delivery significantly enhanced recovery of blood perfusion to the ischemic limb, increased angiogenesis and arteriogenesis, and promoted expression of the protein kinase Akt, endothelial nitric oxide synthase (eNOS), and angiogenic growth factors. These effects were blocked in mice administered a nitric oxide synthase inhibitor, or in eNOS-deficient mice.
CONCLUSIONS: NP-mediated cell-selective statin delivery may be a more effective and integrative strategy for therapeutic neovascularization in patients with severe organ ischemia.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19325146     DOI: 10.1161/ATVBAHA.108.182584

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  18 in total

1.  Drug Delivery and Nanoformulations for the Cardiovascular System.

Authors:  W J Geldenhuys; M T Khayat; J Yun; M A Nayeem
Journal:  Res Rev Drug Deliv       Date:  2017-03-07

Review 2.  Insights into atherosclerosis using nanotechnology.

Authors:  Ashwath Jayagopal; Macrae F Linton; Sergio Fazio; Frederick R Haselton
Journal:  Curr Atheroscler Rep       Date:  2010-05       Impact factor: 5.113

3.  Mixing of the old with the new: nanoparticle-mediated pioglitazone delivery to enhance therapeutic neovascularization.

Authors:  Calvin C Sheng; Charles C Hong
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-10       Impact factor: 8.311

4.  Coupling growth-factor engineering with nanotechnology for therapeutic angiogenesis.

Authors:  Rituparna Sinha Roy; Shivani Soni; Rania Harfouche; Pooja R Vasudevan; Oliver Holmes; Hugo de Jonge; Arthur Rowe; Abhimanyu Paraskar; Dirk M Hentschel; Dimitri Chirgadze; Tom L Blundell; Ermanno Gherardi; Raghunath A Mashelkar; Shiladitya Sengupta
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-16       Impact factor: 11.205

5.  Pitavastatin stimulates retinal angiogenesis via HMG-CoA reductase-independent activation of RhoA-mediated pathways and focal adhesion.

Authors:  Zhi Li; Jing Zhang; Yanni Xue; Ying He; Lanlan Tang; Min Ke; Yan Gong
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-07-30       Impact factor: 3.117

6.  Marked augmentation of PLGA nanoparticle-induced metabolically beneficial impact of γ-oryzanol on fuel dyshomeostasis in genetically obese-diabetic ob/ob mice.

Authors:  Chisayo Kozuka; Chigusa Shimizu-Okabe; Chitoshi Takayama; Kaku Nakano; Hidetaka Morinaga; Ayano Kinjo; Kotaro Fukuda; Asuka Kamei; Akihito Yasuoka; Takashi Kondo; Keiko Abe; Kensuke Egashira; Hiroaki Masuzaki
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

Review 7.  Pleiotropic effects of pitavastatin.

Authors:  Jean Davignon
Journal:  Br J Clin Pharmacol       Date:  2012-04       Impact factor: 4.335

Review 8.  Place of pitavastatin in the statin armamentarium: promising evidence for a role in diabetes mellitus.

Authors:  Yasuyuki Kawai; Ryoko Sato-Ishida; Atsushi Motoyama; Kouji Kajinami
Journal:  Drug Des Devel Ther       Date:  2011-05-11       Impact factor: 4.162

9.  A New Therapeutic Modality for Acute Myocardial Infarction: Nanoparticle-Mediated Delivery of Pitavastatin Induces Cardioprotection from Ischemia-Reperfusion Injury via Activation of PI3K/Akt Pathway and Anti-Inflammation in a Rat Model.

Authors:  Kazuhiro Nagaoka; Tetsuya Matoba; Yajing Mao; Yasuhiro Nakano; Gentaro Ikeda; Shizuka Egusa; Masaki Tokutome; Ryoji Nagahama; Kaku Nakano; Kenji Sunagawa; Kensuke Egashira
Journal:  PLoS One       Date:  2015-07-13       Impact factor: 3.240

10.  Nanoparticle-Mediated Delivery of Irbesartan Induces Cardioprotection from Myocardial Ischemia-Reperfusion Injury by Antagonizing Monocyte-Mediated Inflammation.

Authors:  Yasuhiro Nakano; Tetsuya Matoba; Masaki Tokutome; Daiki Funamoto; Shunsuke Katsuki; Gentaro Ikeda; Kazuhiro Nagaoka; Ayako Ishikita; Kaku Nakano; Jun-Ichiro Koga; Kenji Sunagawa; Kensuke Egashira
Journal:  Sci Rep       Date:  2016-07-11       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.